Sinovac Biotech
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 2 papers. Top paper: “Type II Glycoengineered Anti-CD20 Antibody MIL62 or Cyclosporine in Chinese Primary Membranous Nephropathy: A Multicenter, Randomized, Open-Label Phase 1b/2 Trial”.
Alexandra P. Lewis, Hua Zhou, Hong Li Lin, Guangqun Xing, Wei Chen +22 more
Zhao Cui, Alexandra P. Lewis, Hua Zhou, Hong L. Lin, Guangqun Xing +23 more